The Discounted Cash Flow (DCF) valuation of Haemonetics Corp (HAE) is 107.41 USD. With the latest stock price at 102.84 USD, the upside of Haemonetics Corp based on DCF is 4.4%.
Based on the latest price of 102.84 USD and our DCF valuation, Haemonetics Corp (HAE) is a buy. buying HAE stocks now will result in a potential gain of 4.4%.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 8.8% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 57.40 - 367.99 | 107.41 |
| Upside | -44.2% - 257.8% | 4.4% |